What Is the Present Pathogenetic Concept of Glaucomatous Optic Neuropathy?

Survey of Ophthalmology

Volumn 52, Issue 6 SUPPL., 2007, Pages

  Flammer, Josef ^a   Mozaffarieh, Maneli ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

glaucomatous optic neuropathy; ocular blood flow; oxidative stress; pathogenetic; reperfusion damage; risk factors; vascular dysregulation

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIN; METALLOPROTEINASE; NITRIC OXIDE; PEROXYNITRITE; SUPEROXIDE;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL ACTIVATION; DISEASE ASSOCIATION; DISEASE MARKER; EYE BLOOD FLOW; GLAUCOMA; GLIA CELL; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; JAPANESE; LYMPHOCYTE; MITOCHONDRION; NERVE FIBER; NERVOUS TISSUE; NONHUMAN; OCULAR BLOOD VESSEL; OPTIC NERVE; OPTIC NERVE DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; VASOCONSTRICTION; VEIN OCCLUSION;

GLAUCOMA; HUMANS; OPTIC NERVE DISEASES; RISK FACTORS;

EID: 35848962737     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2007.08.012     Document Type: Article

References (133)

1. Abdal H., Pizzimenti J.J., and Purvis C.C. The eye in sleep apnea syndrome. Sleep Med 7 (2006) 107-115
2. Agapova O.A., Ricard C.S., Salvador-Silva M., et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 33 (2001) 205-216
3. Albrecht M.C., Kaufman P.L., Lutjen-Drecoll E., et al. Choroidal innervation and optic neuropathy in macacque monkeys with laser- or anterior chamber perfusion-induced short-term elevation of intraocular pressure. Exp Eye Res 82 (2006) 1060-1067
4. Anderson D.R., Drance S.M., Schulzer M., et al. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol 136 (2003) 820-829
5. Andrews R.M., Griffiths P.G., Johnson M.A., et al. Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br J Ophthalmol 83 (1999) 231-235
6. Asrani S., Zeimer R., Wilensky J., et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 9 (2000) 134-142
7. Beltrame J.F., Sasayama S., and Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33 (1999) 1442-1452
8. Brandt J.D. Corneal thickness in glaucoma screening, diagnosis, and management. Curr Opin Ophthalmol 15 (2004) 85-89
9. Brandt J.D., Beiser J.A., Gordon M.O., et al. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol 138 (2004) 717-722
10. Chintala S.K., Zhang X., Austin J.S., et al. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 277 (2002) 47461-47468
11. Collignon N., Dewe W., Guillaume S., et al. Ambulatory blood pressure monitoring in glaucoma patients. The nocturnal systolic dip and its relationship with disease progression. Int Ophthalmol 22 (1998) 19-25
12. de la Monte S.M., Garner W., and Wands J.R. Neuronal thread protein gene modulation with cerebral infarction. J Cereb Blood Flow Metab 17 (1997) 623-635
13. Demailly P., Cambien F., Plouin P.F., et al. Do patients with low tension glaucoma have particular cardiovascular characteristics?. Ophthalmologica 188 (1984) 65-75
14. Doyle A., Bensaid A., and Lachkar Y. Central corneal thickness and vascular risk factors in normal tension glaucoma. Acta Ophthalmol Scand 83 (2005) 191-195
15. Drance S.M. The visual field of low tension glaucoma and shock-induced optic neuropathy. Arch Ophthalmol 95 (1977) 1359-1361
16. Drance S.M., Morgan R.W., and Sweeney V.P. Shock-induced optic neuropathy: a cause of nonprogressive glaucoma. N Engl J Med 288 (1973) 392-395
17. Duan X.M., Zou Y.H., Liu X.L., et al. [Visual fields changes in chronic angle closure glaucoma patients after their intraocular pressures were well controlled]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26 (2004) 410-414
18. Emre M., Orgül S., Haufschild T., et al. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol 89 (2005) 60-63
19. Flammer J. [Glaucomatous optic neuropathy: a reperfusion injury]. Klin Monatsbl Augenheilkd 218 (2001) 290-291
20. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol 38 Suppl (1994) S3-S6
21. Flammer J. Glaucoma: a guide for patients (2006), Hofgrefe and Huber Publishers, Seattle, WA, Bern
22. Flammer J., Eppler E., and Niesel P. [Quantitative perimetry in the glaucoma patient without local visual field defects]. Graefes Arch Clin Exp Ophthalmol 219 (1982) 92-94
23. Flammer J., Guthauser U., and Mahler F. Do ocular vasospasms help cause normal tension glaucoma?. Doc Ophthalmol Proc Series 49 (1987) 397-399
24. Flammer J., Haefliger I.O., Orgül S., et al. Vascular dysregulation: a principal risk factor for glaucomatous damage?. J Glaucoma 8 (1999) 212-219
25. Flammer J., Kaiser H., and Haufschild T. Susac syndrome: a vasospastic disorder?. Eur J Ophthalmol 11 (2001) 175-179
26. Flammer J., Orgül S., Costa V.P., et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21 (2002) 359-393
27. Flammer J., Pache M., and Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 20 (2001) 319-349
28. Freyler H., Novack G.D., Menapace R., et al. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma]. Klin Monatsbl Augenheilkd 193 (1988) 257-260
29. Fujino H., Kohzuki H., Takeda I., et al. Regression of capillary network in atrophied soleus muscle induced by hindlimb unweighting. J Appl Physiol 98 (2005) 1407-1413
30. Galassi F., Sodi A., Ucci F., et al. Ocular hemodynamics and glaucoma prognosis: a color Doppler imaging study. Arch Ophthalmol 121 (2003) 1711-1715
31. Gasser P., and Flammer J. Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma. Am J Ophthalmol 111 (1991) 585-588
32. Gasser P., and Meienberg O. Finger microcirculation in classical migraine. A video-microscopic study of nailfold capillaries. Eur Neurol 31 (1991) 168-171
33. Gasser P., Stümpfig D., Schötzau A., et al. Body mass index in glaucoma. J Glaucoma 8 (1999) 8-11
34. Gherghel D., Orgül S., Dubler B., et al. Is vascular regulation in the central retinal artery altered in persons with vasospasm?. Arch Ophthalmol 117 (1999) 1359-1362
35. Gherghel D., Orgül S., Gugleta K., et al. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am J Ophthalmol 130 (2000) 597-605
36. Golubnitschaja O., Flammer J., et al. What are the biomarkers for glaucoma?. Surv Ophthalmol 52 Suppl 2 (2007) S155-S161
37. Golubnitschaja O., Wunderlich K., Decker C., et al. Molecular imaging of perfusion disturbances in glaucoma. Amino Acids 23 (2002) 293-299
38. Golubnitschaja O., Yeghiazaryan K., Liu R., et al. Increased expression of matrix metalloproteinases in mononuclear blood cells of normal-tension glaucoma patients. J Glaucoma 13 (2004) 66-72
39. Golubnitschaja-Labudova O., Liu R., Decker C., et al. Altered gene expression in lymphocytes of patients with normal-tension glaucoma. Curr Eye Res 21 (2000) 867-876
40. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 714-720 discussion 829-30
41. Graham S.L., Drance S.M., Wijsman K., et al. Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip. Ophthalmology 102 (1995) 61-69
42. Grieshaber M.C., and Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol 16 (2005) 79-83
43. Grieshaber M.C., Orgul S., Schoetzau A., et al. Relationship between retinal glial cell activation in glaucoma and vascular dysregulation. J Glaucoma 16 (2007) 215-219
44. Grieshaber M.C., Staub J.J., and Flammer J. The potential role of testosterone in central serous chorioretinopathy. Br J Ophthalmol 91 (2007) 118-119
45. Grieshaber M.C., Sunaric G., and Flammer J. What is the link between vascular dysregulation and glaucoma?. Surv Ophthalmol 52 Suppl 2 (2007) xxx-xxx
46. Grieshaber M.C., Terhorst T., and Flammer J. The pathogenesis of optic disc splinter haemorrhages: a new hypothesis. Acta Ophthalmol Scand 84 (2006) 62-68
47. Gugleta K., Kochkorov A., Katamay R., et al. On pulse-wave propagation in the ocular circulation. Invest Ophthalmol Vis Sci 47 (2006) 4019-4025
48. Gugleta K., Zawinka C., Rickenbacher I., et al. Analysis of retinal vasodilation after flicker light stimulation in relation to vasospastic propensity. Invest Ophthalmol Vis Sci 47 (2006) 4034-4041
49. Guo G., and Bhat N.R. Hypoxia/reoxygenation differentially modulates NF-kappaB activation and iNOS expression in astrocytes and microglia. Antioxid Redox Signal 8 (2006) 911-918
50. Guo L., Moss S.E., Alexander R.A., et al. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 46 (2005) 175-182
51. Gupta N., Ang L.C., Noël de Tilly L., et al. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 90 (2006) 674-678
52. Gupta N., Ly T., Zhang Q., et al. Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp Eye Res 84 (2007) 176-184
53. Gute D.C., Ishida T., Yarimizu K., et al. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179 (1998) 169-187
54. Guthauser U., Flammer J., and Mahler F. The relationship between digital and ocular vasospasm. Graefes Arch Clin Exp Ophthalmol 226 (1988) 224-226
55. Haefliger I.O., Dettmann E., Liu R., et al. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv Ophthalmol 43 Suppl 1 (1999) S51-S58
56. Hafez A.S., Bizzarro R., Descovich D., et al. Correlation between finger blood flow and changes in optic nerve head blood flow following therapeutic intraocular pressure reduction. J Glaucoma 14 (2005) 448-454
57. Haufschild T., Shaw S.G., Kesselring J., et al. Increased endothelin-1 plasma levels in patients with multiple sclerosis. J Neuroophthalmol 21 (2001) 37-38
58. He P., Zhang H., Zhu L., et al. Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: role of activated endothelial cells. Am J Physiol Heart Circ Physiol 291 (2006) H591-H599
59. Hernandez M.R., Agapova O.A., Yang P., et al. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia 38 (2002) 45-64
60. Kaiser H.J., and Flammer J. Systemic Hypotension: a risk factor for glaucomatous damage?. Ophthalmologica 203 (1991) 15-18
61. Kaiser H.J., Flammer J., Graf T., et al. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 231 (1993) 677-680
62. Kaiser H.J., Flammer J., Messerli J., et al. Vasospasm-a risk factor for nonarteric anterior ischaemic optic neuropathy?. Neuro Ophthalmol 16 (1996) 5-10
63. Kaiser H.J., Schoetzau A., Stümpfig D., et al. Blood-flow velocities of the extraocular vessels in patients with high-tension and normal-tension primary open-angle glaucoma. Am J Ophthalmol 123 (1997) 320-327
64. Karageuzyan K.G. Oxidative stress in the molecular mechanism of pathogenesis at different diseased states of organism in clinics and experiment. Curr Drug Targets Inflamm Allergy 4 (2005) 85-98
65. Kirwan R.P., Crean J.K., Fenerty C.H., et al. Effect of cyclical mechanical stretch and exogenous transforming growth factor-beta1 on matrix metalloproteinase-2 activity in lamina cribrosa cells from the human optic nerve head. J Glaucoma 13 (2004) 327-334
66. Kitazawa Y., Shirato S., and Yamamoto T. Optic disc hemorrhage in low-tension glaucoma. Ophthalmology 93 (1986) 853-857
67. Kochkorov A., Gugleta K., Zawinka C., et al. Short-term retinal vessel diameter variability in relation to the history of cold extremities. Invest Ophthalmol Vis Sci 47 (2006) 4026-4033
68. Kunimatsu S., Mayama C., Tomidokoro A., et al. Plasma endothelin-1 level in Japanese normal tension glaucoma patients. Curr Eye Res 31 (2006) 727-731
69. Kvetnoy M., Hernandez-Yago J., Kvetnaia V., et al. Tau-protein expression in human blood lymphocytes: a promising marker and suitable sample for life-time diagnosis of Alzheimer's disease. Neuro Endocrinol Lett 21 (2000) 313-318
70. Lichter P.R., Musch D.C., Gillespie B.W., et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108 (2001) 1943-1953
71. Liu B., Chen H., Johns T.G., et al. Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J Neurosci 26 (2006) 7532-7540
72. Luthra A., Gupta N., Kaufman P.L., et al. Oxidative injury by peroxynitrite in neural and vascular tissue of the lateral geniculate nucleus in experimental glaucoma. Exp Eye Res 80 (2005) 43-49
73. Lütjen-Drecoll E. Choroidal innervation in primate eyes. Exp Eye Res 82 (2006) 357-361
74. Manabe S., Gu Z., and Lipton S.A. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 46 (2005) 4747-4753
75. Martínez A., and Sánchez M. Predictive value of colour Doppler imaging in a prospective study of visual field progression in primary open-angle glaucoma. Acta Ophthalmol Scand 83 (2005) 716-722
76. McNab A.A. Floppy eyelid syndrome and obstructive sleep apnea. Ophthal Plast Reconstr Surg 13 (1997) 98-114
77. Messerli J., and Flammer J. [Central vein thrombosis in younger patients]. Klin Monatsbl Augenheilkd 208 (1996) 303-305
78. Metea M.R., and Newman E.A. Signaling within the neurovascular unit in the retina. Exp Physiol 92 (2007) 635-640
79. Mocco J., Ransom E.R., Komotar R.J., et al. Racial differences in cerebral vasospasm: a systematic review of the literature. Neurosurgery 58 (2006) 305-314
80. Moenkemann H., Flammer J., Wunderlich K., et al. Increased DNA breaks and up-regulation of both G(1) and G(2) checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in circulating leukocytes of glaucoma patients and vasospastic individuals. Amino Acids 28 (2005) 199-205
81. Mojon D.S., Hess C.W., Goldblum D., et al. High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology 106 (1999) 1009-1012
82. Mozaffarieh M., and Flammer J. Is there more to glaucoma treatment than lowering IOP?. Surv Ophthalmol 52 Suppl 2 (2007) S174-S179
83. Mozaffarieh M, Grieshaber MC, Orgul S, et al: The potential value of natural antioxidative treatment in glaucoma. Submitted.
84. Nakabayashi M. Review of the ischemia hypothesis for ocular hypertension other than congenital glaucoma and closed-angle glaucoma. Ophthalmologica 218 (2004) 344-349
85. Neufeld A.H., Hernandez M.R., and Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol 115 (1997) 497-503
86. Neufeld A.H., and Liu B. Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist 9 (2003) 485-495
87. Nicolela M.T., Drance S.M., Rankin S.J., et al. Color Doppler imaging in patients with asymmetric glaucoma and unilateral visual field loss. Am J Ophthalmol 121 (1996) 502-510
88. Niesel P., and Flammer J. Correlations between intraocular pressure, visual field and visual acuity, based on 11 years of observations of treated chronic glaucomas. Int Ophthalmol 3 (1980) 31-35
89. Oh S.W., Lee S., Park C., et al. Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome. Diabetes Metab Res Rev 21 (2005) 434-440
90. Ohuchi T., Yanagisawa M., and Gariepy C.E. Renal tubular effects of endothelin-B receptor signaling: its role in cardiovascular homeostasis and extracellular volume regulation. Curr Opin Nephrol Hypertens 9 (2000) 435-439
91. Orgul S., Flammer J., Gasser P., et al. Female preponderance in normal tension glaucoma. Ann Ophthalmol 27 (1995) 355-359
92. Orgül S., Kaiser H.J., Flammer J., et al. Systemic blood pressure and capillary blood-cell velocity in glaucoma patients: a preliminary study. Eur J Ophthalmol 5 (1995) 88-91
93. Pache M., and Flammer J. A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv Ophthalmol 51 (2006) 179-212
94. Pache M., Kaiser H.J., Akhalbedashvili N., et al. Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis. Eur Neurol 49 (2003) 164-168
95. Pache M., Kräuchi K., Cajochen C., et al. Cold feet and prolonged sleep-onset latency in vasospastic syndrome. Lancet 358 (2001) 125-126
96. Pache M., Schwarz H.A., Kaiser H.J., et al. Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Med Sci Monit 8 (2002) CR616-CR619
97. Phelps C.D., and Corbett J.J. Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci 26 (1985) 1105-1108
98. Pillunat L.E., and Stodtmeister R. Inzidenz des niederdruckglaukoms bei haemodynamisch relevanter karotisstenose. Spektrum Augenheilkd 2 (1987) 24-27
99. Prasanna G., Krishnamoorthy R., Clark A.F., et al. Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci 43 (2002) 2704-2713
100. Prünte C., and Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121 (1996) 26-34
101. Quigley H.A., and Green W.R. The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology 86 (1979) 1803-1830
102. Rader J., Feuer W.J., and Anderson D.R. Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies. Am J Ophthalmol 117 (1994) 72-80
103. Rogers D.L., Cantor R.N., Catoira Y., et al. Central corneal thickness and visual field loss in fellow eyes of patients with open-angle glaucoma. Am J Ophthalmol 143 (2007) 159-161
104. Saner H., Würbel H., Mahler F., et al. Microvasculatory evaluation of vasospastic syndromes. Adv Exp Med Biol 220 (1987) 215-218
105. Satilmis M., Orgül S., Doubler B., et al. Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure. Am J Ophthalmol 135 (2003) 664-669
106. Schlötzer-Schrehardt U., Stojkovic M., Hofmann-Rummelt C., et al. The Pathogenesis of floppy eyelid syndrome: involvement of matrix metalloproteinases in elastic fiber degradation. Ophthalmology 112 (2005) 694-704
107. Schwartz B., Tomita G., and Takamoto T. Glaucoma-like discs with subsequent increased ocular pressures. Ophthalmology 98 (1991) 41-49
108. Sossi N., and Anderson D.R. Blockage of axonal transport in optic nerve induced by elevation of intraocular pressure. Effect of arterial hypertension induced by angiotensin I. Arch Ophthalmol 101 (1983) 94-97
109. Sossi N., and Anderson D.R. Effect of elevated intraocular pressure on blood flow. Occurrence in cat optic nerve head studied with iodoantipyrine I 125. Arch Ophthalmol 101 (1983) 98-101
110. Sugiyama K., Tomita G., Kitazawa Y., et al. The associations of optic disc hemorrhage with retinal nerve fiber layer defect and peripapillary atrophy in normal-tension glaucoma. Ophthalmology 104 (1997) 1926-1933
111. Suzuki Y., Iwase A., Araie M., et al. Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study. Ophthalmology 113 (2006) 1613-1617
112. Taniguchi T., Shimazawa M., Sasaoka M., et al. Endothelin-1 impairs retrograde axonal transport and leads to axonal injury in rat optic nerve. Curr Neurovasc Res 3 (2006) 81-88
113. Tazaki T., Minoguchi K., Yokoe T., et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 170 (2004) 1354-1359
114. Teuchner B., Orgül S., Ulmer H., et al. Reduced thirst in patients with a vasospastic syndrome. Acta Ophthalmol Scand 82 (2004) 738-740
115. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25 (2006) 490-513
116. Tezel G., and Wax M.B. Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head. Arch Ophthalmol 122 (2004) 1348-1356
117. von Worch A., and Kaestner R. Das glaukom ohne hochdruck. Folia Ophthalmol 10 (1985) 221-224
118. Waldmann E., Gasser P., Dubler B., et al. Silent myocardial ischemia in glaucoma and cataract patients. Graefes Arch Clin Exp Ophthalmol 234 (1996) 595-598
119. Wang L., Cioffi G.A., Cull G., et al. Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest Ophthalmol Vis Sci 43 (2002) 1088-1094
120. Wang N., Chintala S.K., Fini M.E., et al. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med 7 (2001) 304-309
121. Wax M.B., and Tezel G. Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection. Mol Neurobiol 26 (2002) 45-55
122. Wax M.B., Tezel G., and Edward P.D. Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma. Arch Ophthalmol 116 (1998) 993-1001
123. Weber A.J., Kaufman P.L., and Hubbard W.C. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Ophthalmol Vis Sci 39 (1998) 2304-2320
124. Weber J., Koll W., and Krieglstein G.K. Intraocular pressure and visual field decay in chronic glaucoma. Ger J Ophthalmol 2 (1993) 165-169
125. Wu L.L., Suzuki Y., Ideta R., et al. Central corneal thickness of normal tension glaucoma patients in Japan. Jpn J Ophthalmol 44 (2000) 643-647
126. Wunderlich K., Golubnitschaja O., Pache M., et al. Increased plasma levels of 20S proteasome alpha-subunit in glaucoma patients: an observational pilot study. Mol Vis 8 (2002) 431-435
127. Wunderlich K., Zimmerman C., Gutmann H., et al. Vasospastic persons exhibit differential expression of ABC-transport proteins. Mol Vis 9 (2003) 756-761
128. Yang J., Yang P., Tezel G., et al. Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia. Invest Ophthalmol Vis Sci 42 (2001) 365-371
129. Yang P., Agapova O., Parker A., et al. DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressure. Physiol Genomics 17 (2004) 157-169
130. Yeghiazaryan K., Flammer J., Wunderlich K., et al. An enhanced expression of ABC 1 transporter in circulating leukocytes as a potential molecular marker for the diagnostics of glaucoma. Amino Acids 28 (2005) 207-211
131. Yoshida M., Ishikawa M., Kokaze A., et al. Association of life-style with intraocular pressure in middle-aged and older Japanese residents. Jpn J Ophthalmol 47 (2003) 191-198
132. Zhang C., Hua T., Zhu Z., et al. Age-related changes of structures in cerebellar cortex of cat. J Biosci 31 (2006) 55-60
133. Zhang X., and Neufeld A.H. Activation of the epidermal growth factor receptor in optic nerve astrocytes leads to early and transient induction of cyclooxygenase-2. Invest Ophthalmol Vis Sci 46 (2005) 2035-2041